Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Could a specific exercise programme prevent injury in elite orienteerers? A randomised controlled trial.

Halvarsson B, von Rosen P.

Phys Ther Sport. 2019 Nov;40:177-183. doi: 10.1016/j.ptsp.2019.09.010. Epub 2019 Sep 24.

PMID:
31586871
2.

Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.

Went M, Sud A, Försti A, Halvarsson BM, Weinhold N, Kimber S, van Duin M, Thorleifsson G, Holroyd A, Johnson DC, Li N, Orlando G, Law PJ, Ali M, Chen B, Mitchell JS, Gudbjartsson DF, Kuiper R, Stephens OW, Bertsch U, Broderick P, Campo C, Bandapalli OR, Einsele H, Gregory WA, Gullberg U, Hillengass J, Hoffmann P, Jackson GH, Jöckel KH, Johnsson E, Kristinsson SY, Mellqvist UH, Nahi H, Easton D, Pharoah P, Dunning A, Peto J, Canzian F, Swerdlow A, Eeles RA, Kote-Jarai Z, Muir K, Pashayan N; PRACTICAL consortium, Nickel J, Nöthen MM, Rafnar T, Ross FM, da Silva Filho MI, Thomsen H, Turesson I, Vangsted A, Andersen NF, Waage A, Walker BA, Wihlborg AK, Broyl A, Davies FE, Thorsteinsdottir U, Langer C, Hansson M, Goldschmidt H, Kaiser M, Sonneveld P, Stefansson K, Morgan GJ, Hemminki K, Nilsson B, Houlston RS.

Nat Commun. 2019 Jan 10;10(1):213. doi: 10.1038/s41467-018-08107-8.

3.

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.

Went M, Sud A, Försti A, Halvarsson BM, Weinhold N, Kimber S, van Duin M, Thorleifsson G, Holroyd A, Johnson DC, Li N, Orlando G, Law PJ, Ali M, Chen B, Mitchell JS, Gudbjartsson DF, Kuiper R, Stephens OW, Bertsch U, Broderick P, Campo C, Bandapalli OR, Einsele H, Gregory WA, Gullberg U, Hillengass J, Hoffmann P, Jackson GH, Jöckel KH, Johnsson E, Kristinsson SY, Mellqvist UH, Nahi H, Easton D, Pharoah P, Dunning A, Peto J, Canzian F, Swerdlow A, Eeles RA, Kote-Jarai Z, Muir K, Pashayan N, Nickel J, Nöthen MM, Rafnar T, Ross FM, da Silva Filho MI, Thomsen H, Turesson I, Vangsted A, Andersen NF, Waage A, Walker BA, Wihlborg AK, Broyl A, Davies FE, Thorsteinsdottir U, Langer C, Hansson M, Goldschmidt H, Kaiser M, Sonneveld P, Stefansson K, Morgan GJ, Hemminki K, Nilsson B, Houlston RS; PRACTICAL consortium.

Nat Commun. 2018 Sep 13;9(1):3707. doi: 10.1038/s41467-018-04989-w. Erratum in: Nat Commun. 2019 Jan 10;10(1):213.

4.

Preventing lower extremity injury in elite orienteerers: study protocol for a randomised controlled trial.

von Rosen P, Halvarsson B.

BMJ Open Sport Exerc Med. 2018 Apr 20;4(1):e000347. doi: 10.1136/bmjsem-2018-000347. eCollection 2018.

5.

Direct evidence for a polygenic etiology in familial multiple myeloma.

Halvarsson BM, Wihlborg AK, Ali M, Lemonakis K, Johnsson E, Niroula A, Cibulskis C, Weinhold N, Försti A, Alici E, Langer C, Pfreundschuh M, Goldschmidt H, Mellqvist UH, Turesson I, Waage A, Hemminki K, Golub T, Nahi H, Gullberg U, Hansson M, Nilsson B.

Blood Adv. 2017 Apr 7;1(10):619-623. doi: 10.1182/bloodadvances.2016003111. eCollection 2017 Apr 11.

6.

Genome-wide association study identifies multiple susceptibility loci for multiple myeloma.

Mitchell JS, Li N, Weinhold N, Försti A, Ali M, van Duin M, Thorleifsson G, Johnson DC, Chen B, Halvarsson BM, Gudbjartsson DF, Kuiper R, Stephens OW, Bertsch U, Broderick P, Campo C, Einsele H, Gregory WA, Gullberg U, Henrion M, Hillengass J, Hoffmann P, Jackson GH, Johnsson E, Jöud M, Kristinsson SY, Lenhoff S, Lenive O, Mellqvist UH, Migliorini G, Nahi H, Nelander S, Nickel J, Nöthen MM, Rafnar T, Ross FM, da Silva Filho MI, Swaminathan B, Thomsen H, Turesson I, Vangsted A, Vogel U, Waage A, Walker BA, Wihlborg AK, Broyl A, Davies FE, Thorsteinsdottir U, Langer C, Hansson M, Kaiser M, Sonneveld P, Stefansson K, Morgan GJ, Goldschmidt H, Hemminki K, Nilsson B, Houlston RS.

Nat Commun. 2016 Jul 1;7:12050. doi: 10.1038/ncomms12050.

7.

Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.

Swaminathan B, Thorleifsson G, Jöud M, Ali M, Johnsson E, Ajore R, Sulem P, Halvarsson BM, Eyjolfsson G, Haraldsdottir V, Hultman C, Ingelsson E, Kristinsson SY, Kähler AK, Lenhoff S, Masson G, Mellqvist UH, Månsson R, Nelander S, Olafsson I, Sigurðardottir O, Steingrimsdóttir H, Vangsted A, Vogel U, Waage A, Nahi H, Gudbjartsson DF, Rafnar T, Turesson I, Gullberg U, Stefánsson K, Hansson M, Thorsteinsdóttir U, Nilsson B.

Nat Commun. 2015 May 26;6:7213. doi: 10.1038/ncomms8213.

8.

Celiac disease can be predicted by high levels of anti-tissue transglutaminase antibodies in population-based screening.

Webb C, Norström F, Myléus A, Ivarsson A, Halvarsson B, Högberg L, Lagerqvist C, Rosén A, Sandström O, Stenhammar L, Carlsson A.

J Pediatr Gastroenterol Nutr. 2015 Jun;60(6):787-91. doi: 10.1097/MPG.0000000000000688.

PMID:
25564816
9.

Efficient and reproducible identification of mismatch repair deficient colon cancer: validation of the MMR index and comparison with other predictive models.

Joost P, Bendahl PO, Halvarsson B, Rambech E, Nilbert M.

BMC Clin Pathol. 2013 Dec 17;13(1):33. doi: 10.1186/1472-6890-13-33.

10.

Prevalence of childhood celiac disease and changes in infant feeding.

Ivarsson A, Myléus A, Norström F, van der Pals M, Rosén A, Högberg L, Danielsson L, Halvarsson B, Hammarroth S, Hernell O, Karlsson E, Stenhammar L, Webb C, Sandström O, Carlsson A.

Pediatrics. 2013 Mar;131(3):e687-94. doi: 10.1542/peds.2012-1015. Epub 2013 Feb 18.

PMID:
23420914
11.

Gain of chromosomal region 20q and loss of 18 discriminates between Lynch syndrome and familial colorectal cancer.

Therkildsen C, Jönsson G, Dominguez-Valentin M, Nissen A, Rambech E, Halvarsson B, Bernstein I, Borg K, Nilbert M.

Eur J Cancer. 2013 Apr;49(6):1226-35. doi: 10.1016/j.ejca.2012.11.011. Epub 2012 Dec 11.

PMID:
23245329
12.

Accuracy in celiac disease diagnostics by controlling the small-bowel biopsy process.

Webb C, Halvarsson B, Norström F, Myléus A, Carlsson A, Danielsson L, Högberg L, Ivarsson A, Karlsson E, Stenhammar L, Sandström O.

J Pediatr Gastroenterol Nutr. 2011 May;52(5):549-53. doi: 10.1097/MPG.0b013e3181fa434f.

PMID:
21502825
13.

Interobserver variability in the evaluation of mismatch repair protein immunostaining.

Klarskov L, Ladelund S, Holck S, Roenlund K, Lindebjerg J, Elebro J, Halvarsson B, von Salomé J, Bernstein I, Nilbert M.

Hum Pathol. 2010 Oct;41(10):1387-96. doi: 10.1016/j.humpath.2010.03.003. Epub 2010 Jun 22.

PMID:
20573374
14.

Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome.

Jensen UB, Sunde L, Timshel S, Halvarsson B, Nissen A, Bernstein I, Nilbert M.

Breast Cancer Res Treat. 2010 Apr;120(3):777-82. doi: 10.1007/s10549-009-0449-3. Epub 2009 Jul 3.

PMID:
19575290
15.

Prognostic impact of array-based genomic profiles in esophageal squamous cell cancer.

Carneiro A, Isinger A, Karlsson A, Johansson J, Jönsson G, Bendahl PO, Falkenback D, Halvarsson B, Nilbert M.

BMC Cancer. 2008 Apr 11;8:98. doi: 10.1186/1471-2407-8-98.

16.

Clinicopathologic factors identify sporadic mismatch repair-defective colon cancers.

Halvarsson B, Anderson H, Domanska K, Lindmark G, Nilbert M.

Am J Clin Pathol. 2008 Feb;129(2):238-44. doi: 10.1309/0PP5GDRTXUDVKAWJ.

PMID:
18208804
17.

Cost-efficient operation of a denitrifying activated sludge process.

Samuelsson P, Halvarsson B, Carlsson B.

Water Res. 2007 Jun;41(11):2325-32. Epub 2007 Apr 23.

PMID:
17451780
18.

Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.

Lagerstedt Robinson K, Liu T, Vandrovcova J, Halvarsson B, Clendenning M, Frebourg T, Papadopoulos N, Kinzler KW, Vogelstein B, Peltomäki P, Kolodner RD, Nilbert M, Lindblom A.

J Natl Cancer Inst. 2007 Feb 21;99(4):291-9.

PMID:
17312306
19.

Phenotypic heterogeneity in hereditary non-polyposis colorectal cancer: identical germline mutations associated with variable tumour morphology and immunohistochemical expression.

Halvarsson B, Müller W, Planck M, Benoni AC, Mangell P, Ottosson J, Hallén M, Isinger A, Nilbert M.

J Clin Pathol. 2007 Jul;60(7):781-6. Epub 2006 Aug 10.

20.

The added value of PMS2 immunostaining in the diagnosis of hereditary nonpolyposis colorectal cancer.

Halvarsson B, Lindblom A, Rambech E, Lagerstedt K, Nilbert M.

Fam Cancer. 2006;5(4):353-8. Epub 2006 Jul 12.

PMID:
16817031
21.

The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.

Malander S, Rambech E, Kristoffersson U, Halvarsson B, Ridderheim M, Borg A, Nilbert M.

Gynecol Oncol. 2006 May;101(2):238-43. Epub 2005 Dec 19.

PMID:
16360201
22.

Loss of mismatch repair protein immunostaining in colorectal adenomas from patients with hereditary nonpolyposis colorectal cancer.

Halvarsson B, Lindblom A, Johansson L, Lagerstedt K, Nilbert M.

Mod Pathol. 2005 Aug;18(8):1095-101.

23.

Defective mismatch-repair as a minor tumorigenic pathway in Barrett esophagus-associated adenocarcinoma.

Falkenback D, Johansson J, Halvarsson B, Nilbert M.

Cancer Genet Cytogenet. 2005 Feb;157(1):82-6.

PMID:
15676154
24.

Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer?

Halvarsson B, Lindblom A, Rambech E, Lagerstedt K, Nilbert M.

Virchows Arch. 2004 Feb;444(2):135-41. Epub 2003 Dec 2.

PMID:
14652751
25.

Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine.

Planck M, Ericson K, Piotrowska Z, Halvarsson B, Rambech E, Nilbert M.

Cancer. 2003 Mar 15;97(6):1551-7.

26.

Defective mismatch-repair in patients with multiple primary tumours including colorectal cancer.

Ericson K, Halvarsson B, Nagel J, Rambech E, Planck M, Piotrowska Z, Olsson H, Nilbert M.

Eur J Cancer. 2003 Jan;39(2):240-8.

PMID:
12509957
27.

Predominance of CIN versus MSI in the development of rectal cancer at young age.

Fernebro E, Halvarsson B, Baldetorp B, Nilbert M.

BMC Cancer. 2002 Oct 14;2:25.

28.

Cytogenetic aberrations and heterogeneity of mutations in repeat-containing genes in a colon carcinoma from a patient with hereditary nonpolyposis colorectal cancer.

Planck M, Halvarsson B, Pålsson E, Hallén M, Ekelund M, Pålsson B, Baldetorp B, Nilbert M.

Cancer Genet Cytogenet. 2002 Apr 1;134(1):46-54.

PMID:
11996796

Supplemental Content

Loading ...
Support Center